Drop the C-word to reduce anxiety and overtreatment, say experts

by University of SydneyCredit: CC0 Public DomainMedical researchers are calling for the word 'cancer' to be dropped from some doctor-patient conversations in a bid to reduce patient anxie

Updated on: April 01,2024

Drop the C-word to reduce anxiety and overtreatment, say experts

by University of SydneyCredit: CC0 Public DomainMedical researchers are calling for the word 'cancer' to be dropped from some doctor-patient conversations in a bid to reduce patient anxie

Updated on:April 01,2024

Unique approach to treatment of rare and aggressive blood cancers

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainA unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and dif

Updated on: April 10,2024

Unique approach to treatment of rare and aggressive blood cancers

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainA unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and dif

Updated on:April 10,2024

Benefits of running in the cold outweigh warm weather running, says expert

by Midwest Orthopaedics at RUSHCredit: CC0 Public DomainSome year-round runners dread plunging temperatures, but according to recent research, the benefits of running in the cold weather outweigh warm

Updated on: April 01,2024

Benefits of running in the cold outweigh warm weather running, says expert

by Midwest Orthopaedics at RUSHCredit: CC0 Public DomainSome year-round runners dread plunging temperatures, but according to recent research, the benefits of running in the cold weather outweigh warm

Updated on:April 01,2024

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on: February 18,2024

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on:February 18,2024

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on: January 02,2024

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on:January 02,2024

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on: December 28,2023

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on:December 28,2023

Putting the brakes on tumor stealth

by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how

Updated on: April 01,2024

Putting the brakes on tumor stealth

by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how

Updated on:April 01,2024

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University

Updated on: January 21,2024

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University

Updated on:January 21,2024

Experts explore the underlying biology of cancer and potential therapeutic strategies

by Beijing Zhongke Journal Publising Co.ABBS: a special issue focused on mechanism-based studies. Credit: Beijing Zhongke Journal Publising Co. Ltd.Cancer's global impact is severe, affecting mill

Updated on: January 22,2024

Experts explore the underlying biology of cancer and potential therapeutic strategies

by Beijing Zhongke Journal Publising Co.ABBS: a special issue focused on mechanism-based studies. Credit: Beijing Zhongke Journal Publising Co. Ltd.Cancer's global impact is severe, affecting mill

Updated on:January 22,2024

Imaging tumor stiffness could help enhance treatment for breast and pancreatic cancer

by Institute of Cancer ResearchKiller T cells surround a cancer cell. Credit: NIHUsing a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about

Updated on: April 07,2024

Imaging tumor stiffness could help enhance treatment for breast and pancreatic cancer

by Institute of Cancer ResearchKiller T cells surround a cancer cell. Credit: NIHUsing a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about

Updated on:April 07,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on: March 30,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on:March 30,2024

Study finds adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

byUniversity of California, Los AngelesCredit: Miguel Á. Padriñán from PexelsA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amoun

Updated on: March 30,2024

Study finds adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

byUniversity of California, Los AngelesCredit: Miguel Á. Padriñán from PexelsA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amoun

Updated on:March 30,2024